673 Stock Overview
An investment holding company, engages in the distribution and services of medical equipment and consumables in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
China Health Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.37 |
| 52 Week High | HK$1.23 |
| 52 Week Low | HK$0.25 |
| Beta | -0.58 |
| 1 Month Change | -32.73% |
| 3 Month Change | -43.94% |
| 1 Year Change | -62.24% |
| 3 Year Change | -22.92% |
| 5 Year Change | -78.24% |
| Change since IPO | -99.61% |
Recent News & Updates
Recent updates
Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns
Sep 05
Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation
Sep 11We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt
Dec 01We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet
Sep 23We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation
Sep 02Did China Health Group Limited (HKG:673) Insiders Sell Shares?
Feb 16
Shareholder Returns
| 673 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -31.5% | 1.6% | 2.1% |
| 1Y | -62.2% | -20.9% | 17.6% |
Return vs Industry: 673 underperformed the Hong Kong Healthcare industry which returned -20.9% over the past year.
Return vs Market: 673 underperformed the Hong Kong Market which returned 17.6% over the past year.
Price Volatility
| 673 volatility | |
|---|---|
| 673 Average Weekly Movement | 25.3% |
| Healthcare Industry Average Movement | 8.4% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 3.9% |
Stable Share Price: 673's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 673's weekly volatility has increased from 14% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 118 | Ho Chung | www.ch-groups.com |
China Health Group Limited, an investment holding company, engages in the distribution and services of medical equipment and consumables in the People’s Republic of China. The company operates through Distribution and Service in Medical Equipment and Consumables; Hospital Operation and Management Services; Business Service; and Research and Development and Sale of Functional Food segments. It is involved in the distribution and marketing of pharmaceutical products, as well as property investment and factoring services business.
China Health Group Limited Fundamentals Summary
| 673 fundamental statistics | |
|---|---|
| Market cap | HK$181.91m |
| Earnings (TTM) | -HK$42.51m |
| Revenue (TTM) | HK$50.34m |
3.6x
P/S Ratio-4.3x
P/E RatioIs 673 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 673 income statement (TTM) | |
|---|---|
| Revenue | HK$50.34m |
| Cost of Revenue | HK$39.75m |
| Gross Profit | HK$10.60m |
| Other Expenses | HK$53.11m |
| Earnings | -HK$42.51m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.086 |
| Gross Margin | 21.05% |
| Net Profit Margin | -84.45% |
| Debt/Equity Ratio | 10.7% |
How did 673 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 21:36 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Health Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|